Laleh Boroujerdi-Rad, MD
Nephrology · Whittier
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 17 years
- Graduated 2009
Offices
1 location · Whittier Internal Medicine and Nephrology Medical Group Inc · 7 clinicians in this group
Looking this up.
Hospitals listed: 052712 · 052884 · 552890 · Pih Health Hospital-Whittier · Whittier Hospital Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Boroujerdi-Rad’s office at (562) 698-8141 to ask if they take your plan before you enroll.
California Medical Board record
Licence A114999 · Current
Licensed to practise in California · since 2010 · expires 2028-12-31 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Pih Health Hospital-WhittierWhittier, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of PIH Health, which runs 3 hospitalsPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.497, Oct 2024 – Sep 2025
- Whittier Hospital Medical CenterWhittier, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.265, Oct 2024 – Sep 2025
See every measure and the patient survey for Pih Health Hospital-Whittier
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.497 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.83 (0 to 1.8) · 1,222 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.77 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.59 (122.43 to 208.75) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 64 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 323 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 360 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 553 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 4,869 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 6,090 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 6,261 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.56 (3.44 to 7.67) · 1,178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.98 (0.31 to 3.64) · 255 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.28 (1.77 to 4.79) · 1,113 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.32 (5.89 to 20.76) · 256 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.43 to 9.49) · 249 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.16 to 3.11) · 236 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.12 (0 to 0.71) · 5,179 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 140 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.594 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.825 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.474 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.445 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.39 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 509 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 1,125 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.1 · 147 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27 · 401 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 30.4 · 400 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 1,019 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.3 to 7.4) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (10.4 to 18.1) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7 · 140 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.6 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 222 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (10.1 to 16.6) · 1,770 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 397 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,178 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Whittier Hospital Medical Center
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 5 the same, 0 worse of 5 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.265 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0 to 2.1) · 342 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.44 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.7 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 40 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.9 · 903 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.42) · 1,603 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,665 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.29 (0.73 to 5.86) · 153 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.67 (0 to 3.4) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.98) · 152 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.99 (0 to 18.96) · 36 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.22 (0.88 to 9.55) · 32 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.32) · 1,393 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 63 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.575 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 191 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 2 · 101 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 15.3 · 199 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 319 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 71 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 96 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.7 to 17.8) · 98 cases | No different | Jan 2022 – Dec 2024 |
What patients said (540 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 79% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$155,832
Medicare paid this office $155,832 for 376 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 252 | $67,999 | $65 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 14 | $36,408 | $294 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 124 | $14,410 | $106 |
| Return visit (30+ min) | 70 | $9,336 | $64 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 14 | $9,038 | $244 |
See all 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 252 | $67,999 | $65 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 14 | $36,408 | $294 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 124 | $14,410 | $106 |
| Return visit (30+ min) | 70 | $9,336 | $64 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 14 | $9,038 | $244 |
| Hospital discharge day management, 30 minutes or less | 32 | $2,358 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,331 | $97 |
| Hemodialysis procedure with physician evaluation | 28 | $2,331 | $58 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 27 | $2,097 | $68 |
| New patient visit (45+ min) | 13 | $1,488 | $114 |
| Short return visit (20+ min) | 11 | $636 | $58 |
Who their Medicare patients are
376 Original Medicare patients in 2024. Average age 74 · Under 65 21% · 85 and older 22% · Women 49% · Also on Medicaid 63% · Health risk score 5.23. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 73% · Heart failure 64% · Coronary heart disease 50% · Atrial fibrillation 44% · Depression 32% · COPD 31% · Stroke 29% · Dementia 27% · Cancer 18%.
The office billed $444,030, Medicare allowed $201,653 and paid $155,832; for 1,711 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 376 | 1,711 | 74 | 5.23 | $444,030 | $155,832 |
| 2023 | 383 | 1,857 | 74 | 5.17 | $492,955 | $180,617 |
| 2022 | 391 | 1,684 | 73 | 4.54 | $490,725 | $180,255 |
| 2021 | 404 | 1,835 | 74 | 4.35 | $587,045 | $222,256 |
| 2020 | 185 | 847 | 70 | 5.32 | $344,435 | $127,481 |
| 2019 | 185 | 995 | 71 | 4.83 | $436,725 | $158,291 |
| 2018 | 179 | 1,058 | 70 | 5.51 | $484,600 | $172,242 |
| 2017 | 153 | 510 | 69 | 5.30 | $150,475 | $57,392 |
| 2016 | 127 | 515 | 71 | 5.05 | $110,675 | $44,667 |
| 2015 | 47 | 148 | 70 | 4.17 | $32,150 | $13,332 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 245 | $69,207 | $66 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 24 | $43,756 | $298 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 133 | $15,761 | $108 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 19 | $14,628 | $248 |
| Return visit (30+ min) | 62 | $10,283 | $81 |
| Hospital discharge day management, 30 minutes or less | 58 | $4,372 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $2,906 | $145 |
| Hemodialysis procedure with physician evaluation | 39 | $2,866 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,381 | $95 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $969 | $69 |
| Short return visit (20+ min) | 12 | $783 | $65 |
2022: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 28 | $52,236 | $307 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 224 | $50,329 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 113 | $20,015 | $167 |
| Return visit (30+ min) | 64 | $12,924 | $101 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 21 | $12,234 | $255 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $6,629 | $86 |
| Hospital discharge day management, 30 minutes or less | 57 | $3,747 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $3,741 | $110 |
| Hemodialysis procedure with physician evaluation | 35 | $3,501 | $61 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 12 | $1,780 | $59 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,101 | $85 |
2021: 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 31 | $83,019 | $316 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 262 | $57,022 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 178 | $34,158 | $173 |
| Return visit (30+ min) | 53 | $10,592 | $111 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $8,901 | $262 |
| Hemodialysis procedure with physician evaluation | 50 | $4,751 | $63 |
| Hospital discharge day management, 30 minutes or less | 70 | $4,489 | $62 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 13 | $2,420 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,529 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,431 | $89 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,208 | $93 |
| Short return visit (20+ min) | 14 | $803 | $57 |
2020: 7 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 34 | $66,854 | $249 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 77 | $14,498 | $62 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $12,514 | $209 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $11,486 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $6,400 | $90 |
| Short return visit (20+ min) | 34 | $2,712 | $63 |
| Return visit (30+ min) | 24 | $2,590 | $86 |
2019: 8 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 48 | $98,747 | $243 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 71 | $13,887 | $62 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $9,908 | $202 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $7,723 | $172 |
| Return visit (30+ min) | 44 | $7,022 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $5,646 | $88 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $3,363 | $116 |
| Short return visit (20+ min) | 35 | $2,991 | $62 |
2018: 8 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 58 | $104,670 | $243 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 47 | $19,246 | $205 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 74 | $15,730 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $8,278 | $172 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,946 | $116 |
| Return visit (30+ min) | 30 | $3,886 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $3,459 | $89 |
| Short return visit (20+ min) | 32 | $2,918 | $62 |
2017: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 34 | $15,683 | $241 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 67 | $13,262 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $11,712 | $172 |
| Return visit (30+ min) | 30 | $4,996 | $93 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 13 | $3,264 | $204 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,750 | $89 |
| New patient visit (45+ min) | 11 | $1,417 | $129 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,394 | $116 |
| Short return visit (20+ min) | 17 | $1,164 | $61 |
2016: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 77 | $18,260 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $11,675 | $172 |
| Return visit (30+ min) | 35 | $6,039 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $4,846 | $88 |
2015: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $4,758 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,936 | $171 |
| Return visit (30+ min) | 16 | $1,853 | $93 |
Medicaid work
$6,503 in 2024
Medicaid paid $6,503 for 342 billed services this clinician did in 2024, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 342 | $6,503 |
| 2024 | 342 | 1 | 21 | $6,503 |
| 2023 | 457 | 2 | 20 | $10,894 |
| 2022 | 162 | 2 | 18 | $3,350 |
| 2021 | 40 | 1 | 14 | $2,308 |
| 2020 | 97 | 3 | 20 | $2,762 |
| 2019 | 166 | 2 | 22 | $5,254 |
| 2018 | 87 | 2 | 16 | $1,928 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 431 | $9,700 |
| Return visit (30+ min) | 26 | $1,194 |
2022
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 150 | $2,899 |
| Return visit (30+ min) | 12 | $450 |
2021
| Return visit (30+ min) | 40 | $2,308 |
2020
| Return visit (30+ min) | 45 | $1,314 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 37 | $786 |
| 1ST HOSP IP/OBS HIGH 75 | 15 | $662 |
2019
| Return visit (30+ min) | 133 | $4,392 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 33 | $862 |
2018
| Return visit (30+ min) | 44 | $1,826 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 43 | $102 |
Drugs they prescribed that Part D paid
$128,857
Pharmacies billed $128,857 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
566 generic and fewer than 11 brand-name prescriptions · $128,857 in drug cost · 30 antibiotic prescriptions to 24 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 45 | $46,337 | $1,030 |
| Lokelma | 19 | $9,563 | $503 |
| Eliquis | 16 | $9,289 | $581 |
| Clinolipid | 31 | $4,031 | $130 |
| Calcium Acetate | 14 | $2,382 | $170 |
See all 16 drugs
| Farxiga | 45 | $46,337 | $1,030 |
| Lokelma | 19 | $9,563 | $503 |
| Eliquis | 16 | $9,289 | $581 |
| Clinolipid | 31 | $4,031 | $130 |
| Calcium Acetate | 14 | $2,382 | $170 |
| Losartan | 59 | $743 | $13 |
| Hydralazine | 31 | $710 | $23 |
| Amlodipine Besylate | 96 | $570 | $6 |
| Lisinopril | 71 | $447 | $6 |
| Labetalol | 14 | $432 | $31 |
| Furosemide | 40 | $302 | $8 |
| Potassium Chloride | 15 | $203 | $14 |
| Calcitriol | 11 | $118 | $11 |
| Atorvastatin | 14 | $100 | $7 |
| Hydrochlorothiazide | 21 | $91 | $4 |
| Metoprolol | 15 | $32 | $2 |
Year by year
| 2024 | 738 | 238 | None | None | $128,857 |
| 2023 | 876 | 250 | None | None | $184,870 |
| 2022 | 708 | 250 | 2% (13) | None | $55,008 |
| 2021 | 904 | 288 | 1% (13) | None | $82,621 |
| 2020 | 876 | 219 | None | None | $77,251 |
| 2019 | 952 | 202 | 0% (0) | None | $89,059 |
| 2018 | 884 | 151 | None | None | $71,187 |
| 2017 | 810 | 131 | None | None | $131,807 |
| 2016 | 549 | 109 | None | None | $82,398 |
| 2015 | 200 | 94 | None | 27% | $32,997 |
| 2014 | 188 | 55 | None | 35% | $85,990 |
| 2013 | 128 | 24 | None | None | $17,491 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Farxiga | 38 | $51,719 | $1,361 |
| Velphoro | 15 | $44,176 | $2,945 |
| Procrit | 23 | $14,761 | $642 |
| Lokelma | 18 | $9,265 | $515 |
| Sevelamer Carbonate | 12 | $7,820 | $652 |
| Hydralazine | 61 | $2,378 | $39 |
| Prosol | 14 | $1,858 | $133 |
| Amlodipine Besylate | 109 | $1,360 | $12 |
| Losartan | 48 | $1,113 | $23 |
| Lisinopril | 72 | $881 | $12 |
| Labetalol | 16 | $856 | $54 |
| Losartan-Hydrochlorothiazide | 13 | $780 | $60 |
| Potassium Chloride | 16 | $561 | $35 |
| Gentamicin Sulfate | 14 | $530 | $38 |
| Furosemide | 58 | $419 | $7 |
| Atorvastatin | 18 | $376 | $21 |
| Hydrochlorothiazide | 29 | $318 | $11 |
| Atenolol | 20 | $241 | $12 |
| Metoprolol | 17 | $189 | $11 |
| Carvedilol | 11 | $141 | $13 |
2022: 14 drugs
| Retacrit | 12 | $6,391 | $533 |
| Sevelamer Carbonate | 11 | $4,397 | $400 |
| Labetalol | 26 | $2,090 | $80 |
| Calcium Acetate | 11 | $1,370 | $125 |
| Hydralazine | 47 | $1,045 | $22 |
| Losartan | 54 | $1,000 | $19 |
| Calcitriol | 24 | $807 | $34 |
| Amlodipine Besylate | 79 | $758 | $10 |
| Nifedipine Er | 11 | $524 | $48 |
| Benazepril | 28 | $474 | $17 |
| Furosemide | 77 | $343 | $4 |
| Lisinopril | 45 | $333 | $7 |
| Atorvastatin | 12 | $170 | $14 |
| Atenolol | 12 | $82 | $7 |
2021: 17 drugs
| Renvela | 12 | $31,228 | $2,602 |
| Sevelamer Carbonate | 17 | $9,177 | $540 |
| Calcium Acetate | 30 | $3,774 | $126 |
| Labetalol | 23 | $1,429 | $62 |
| Losartan | 82 | $1,302 | $16 |
| Hydralazine | 55 | $869 | $16 |
| Calcitriol | 44 | $685 | $16 |
| Amlodipine Besylate | 93 | $592 | $6 |
| Atorvastatin | 27 | $494 | $18 |
| Potassium Chloride | 14 | $435 | $31 |
| Benazepril | 38 | $428 | $11 |
| Lisinopril | 32 | $385 | $12 |
| Furosemide | 97 | $354 | $4 |
| Glipizide Er | 11 | $323 | $29 |
| Levothyroxine | 13 | $299 | $23 |
| Atenolol | 13 | $116 | $9 |
| Metoprolol | 13 | $57 | $4 |
2020: 18 drugs
| Sevelamer Carbonate | 21 | $9,376 | $446 |
| Calcium Acetate | 42 | $3,918 | $93 |
| Labetalol | 40 | $2,487 | $62 |
| Midodrine | 11 | $1,874 | $170 |
| Hydralazine | 78 | $1,845 | $24 |
| Losartan | 60 | $726 | $12 |
| Calcitriol | 30 | $679 | $23 |
| Amlodipine Besylate | 110 | $560 | $5 |
| Furosemide | 92 | $404 | $4 |
| Benazepril | 39 | $395 | $10 |
| Atorvastatin | 23 | $354 | $15 |
| Glipizide Er | 13 | $324 | $25 |
| Lisinopril | 33 | $253 | $8 |
| Atenolol | 25 | $148 | $6 |
| Allopurinol | 15 | $146 | $10 |
| Prednisone | 13 | $144 | $11 |
| Potassium Chloride | 11 | $128 | $12 |
| Omeprazole | 12 | $95 | $8 |
2019: 16 drugs
| Auryxia | 14 | $15,587 | $1,113 |
| Sevelamer Carbonate | 22 | $11,749 | $534 |
| Calcium Acetate | 72 | $8,202 | $114 |
| Sodium Polystyrene Sulfonate | 12 | $2,058 | $171 |
| Labetalol | 47 | $1,937 | $41 |
| Amlodipine Besylate | 147 | $1,674 | $11 |
| Losartan | 78 | $1,326 | $17 |
| Hydralazine | 59 | $1,197 | $20 |
| Furosemide | 99 | $609 | $6 |
| Calcitriol | 33 | $529 | $16 |
| Benazepril | 52 | $479 | $9 |
| Lisinopril | 46 | $452 | $10 |
| Clonidine | 17 | $188 | $11 |
| Carvedilol | 12 | $141 | $12 |
| Gabapentin | 17 | $113 | $7 |
| Allopurinol | 16 | $113 | $7 |
2018: 23 drugs
| Renvela | 12 | $16,440 | $1,370 |
| Sevelamer Carbonate | 18 | $10,335 | $574 |
| Calcium Acetate | 91 | $9,172 | $101 |
| Labetalol | 54 | $2,201 | $41 |
| Sodium Polystyrene Sulfonate | 14 | $1,433 | $102 |
| Nifedipine Er | 17 | $1,206 | $71 |
| Amlodipine Besylate | 76 | $848 | $11 |
| Hydralazine | 46 | $806 | $18 |
| Losartan | 68 | $768 | $11 |
| Omeprazole | 14 | $568 | $41 |
| Calcitriol | 27 | $526 | $19 |
| Benazepril | 46 | $485 | $11 |
| Valsartan | 17 | $435 | $26 |
| Furosemide | 87 | $372 | $4 |
| Allopurinol | 17 | $248 | $15 |
| Atorvastatin | 11 | $235 | $21 |
| Prednisone | 18 | $174 | $10 |
| Warfarin | 14 | $166 | $12 |
| Metolazone | 11 | $94 | $9 |
| Gabapentin | 14 | $88 | $6 |
| Simvastatin | 16 | $86 | $5 |
| Lisinopril | 14 | $49 | $4 |
| Famotidine | 11 | $42 | $4 |
2017: 22 drugs
| Sensipar | 39 | $63,462 | $1,627 |
| Renvela | 25 | $42,338 | $1,694 |
| Calcium Acetate | 66 | $5,135 | $78 |
| Labetalol | 32 | $1,503 | $47 |
| Nifedipine Er | 14 | $1,354 | $97 |
| Valsartan | 30 | $647 | $22 |
| Calcitriol | 44 | $615 | $14 |
| Sodium Polystyrene Sulfonate | 12 | $604 | $50 |
| Lidocaine-Prilocaine | 18 | $595 | $33 |
| Losartan | 47 | $482 | $10 |
| Amlodipine Besylate | 71 | $401 | $6 |
| Warfarin | 16 | $325 | $20 |
| Benazepril | 34 | $246 | $7 |
| Enalapril Maleate | 13 | $244 | $19 |
| Clonidine | 30 | $241 | $8 |
| Furosemide | 62 | $231 | $4 |
| Omeprazole | 11 | $225 | $20 |
| Hydralazine | 12 | $206 | $17 |
| Allopurinol | 19 | $200 | $11 |
| Famotidine | 16 | $62 | $4 |
| Lisinopril | 17 | $53 | $3 |
| Simvastatin | 13 | $45 | $3 |
2016: 21 drugs
| Sensipar | 31 | $35,148 | $1,134 |
| Renvela | 14 | $29,984 | $2,142 |
| Calcium Acetate | 58 | $5,337 | $92 |
| Labetalol | 14 | $633 | $45 |
| Calcitriol | 18 | $560 | $31 |
| Hydralazine | 14 | $492 | $35 |
| Diphenoxylate-Atropine | 11 | $433 | $39 |
| Potassium Chloride | 11 | $366 | $33 |
| Losartan | 36 | $288 | $8 |
| Benazepril | 33 | $248 | $8 |
| Amlodipine Besylate | 31 | $221 | $7 |
| Warfarin | 14 | $176 | $13 |
| Furosemide | 34 | $151 | $4 |
| Minoxidil | 12 | $135 | $11 |
| Carvedilol | 13 | $123 | $9 |
| Metoprolol | 13 | $96 | $7 |
| Lisinopril | 14 | $89 | $6 |
| Clonidine | 17 | $82 | $5 |
| Hydrochlorothiazide | 13 | $81 | $6 |
| Temazepam | 13 | $55 | $4 |
| Famotidine | 12 | $47 | $4 |
2015: 4 drugs
| Sensipar | 17 | $16,339 | $961 |
| Calcium Acetate | 21 | $1,869 | $89 |
| Amlodipine Besylate | 21 | $116 | $6 |
| Furosemide | 13 | $39 | $3 |
2014: 3 drugs
| Sensipar | 37 | $67,054 | $1,812 |
| Calcium Acetate | 12 | $884 | $74 |
| Amlodipine Besylate | 15 | $114 | $8 |
2013: 1 drug
| Benazepril | 11 | $144 | $13 |
Money from drug and device companies
$106 in 2025
| 2025 | 3 | 5 | None | $106 |
| 2024 | 2 | 8 | None | $196 |
| 2023 | 3 | 6 | None | $284 |
| 2021 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Otsuka America Pharmaceutical | Jynarque | $44 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $35 | 2 payments
|
| Ardelyx | Ibsrela | $27 | 1 payment
|
See all 5 published payments
| Ardelyx | Meals · 2025-11-13 | Ibsrela | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-06 | Lokelma | $20 |
| Otsuka America Pharmaceutical | Meals · 2025-06-26 | Jynarque | $19 |
| Otsuka America Pharmaceutical | Meals · 2025-03-18 | Jynarque | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-19 | Lokelma | $16 |
See earlier years (2024, 2023, 2021)
2024: $196
| AstraZeneca Pharmaceuticals LP | Lokelma | $174 | 2 payments
|
| Vifor Pharma | Veltassa | $22 | 1 payment
|
2023: $284
| AstraZeneca Pharmaceuticals LP | Farxiga | $161 | 4 payments
|
| Otsuka America Pharmaceutical | Jynarque | $120 | 1 payment
|
| Travere Therapeutics | None | $3 | 1 payment
|
2021: $23
| Novo Nordisk | Ozempic | $23 | 1 payment
|
Professional record
- NPI
- 1245474378
- Licence
- CA A114999California A114999: Current · expires 2028-12-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 14350 Whittier Blvd Ste 101, Whittier, CA, 90605
- NPI first listed
- 2009-04-20
- NPI last updated
- 2022-07-21
This is when the NPI record was last certified, not a medical board exam.